Physician–Pharmacist Cooperation Program for Blood Pressure Control in Patients With Hypertension: A Randomized-Controlled Trial
スポンサーリンク
概要
- 論文の詳細を見る
関連リソース（relation uri):Response to “Role of Pharmacists in the Management of Hypertensive Patients”American Journal of Hypertension 2011; 24 1, 4. doi:10.1038/ajh.2010.207BackgroundThe aim of the trial was to evaluate the effectiveness of a program of cooperation between physician and pharmacist to reduce cardiovascular risk factors in patients with mild to moderate hypertension by promoting better blood pressure (BP) control, appropriate changes in antihypertensive medications, and beneficial changes in lifestyle.MethodsThe 132 subjects in this randomized, controlled trial were in the age range of 40–79 years. The inclusion criteria were: systolic BP (SBP) ranging from 140–179 mm Hg and/or diastolic BP (DBP) ranging from 90-99 mm Hg and treatment-naive (untreated for hypertension); or on a regimen of medication for hypertension. Of these 132 subjects, 124 (94%) were already receiving treatment with antihypertensive medications. Equal numbers of subjects were randomly assigned to one of two groups: a physician–pharmacist intervention group (n = 66) and a control group (n = 66).ResultsThe 6-month follow-up rate was 97% in both groups. At 6 months, the mean decrease in SBP/DBP, as measured at home in the morning, was 2.9/3.3 mm Hg in the intervention group relative to baseline (P = 0.02 and P < 0.0001 for SBP and DBP, respectively). The mean decrease in home morning SBP in the intervention group was not significantly greater than in the control group. However, the DBP decline was significantly greater in the intervention than control groups, which showed a mean decrease of 2.8 mm Hg (confidence interval: –5.5 to –0.1; P = 0.04). The percentage of patients in whom control of home morning BP was achieved was 53% in the intervention group and 47% in the control group (P = 0.40). A higher percentage of patients in the intervention group, relative to the control group, were able to reduce the use of antihypertensive medications (31 vs. 8%, P < 0.0001), and fewer patients in this group required additional medications or increases in dosage relative to the controls (11 vs. 28%, P = 0.03). Patients of the intervention group were more likely to show reduction in body mass index and sodium intake and to stop smoking, as compared with the control group.ConclusionsA program of cooperation between physician and pharmacist was successful in reducing cardiovascular risk factors in patients with mild to moderate hypertension by promoting better blood pressure (BP) control, appropriate changes in antihypertensive medications, and beneficial changes in lifestyle.
論文 | ランダム
- Bi(Pb)-Sr-Ca-Cu-O系超伝導体の緻密化と臨界電流密度に及ぼす再加圧成形の効果
- Bi (Pb)系酸化物超伝導体の焼結挙動と臨界電流密度に及ぼすアルカリ土類酸化物の添加効果
- 乳歯齲蝕の疫学的研究
- 労働歯科衛生に関する研究-2-
- コンポジルシステムの新技術 : RediflocとHCSを用いる三段階アプローチ